Pooled Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone in Patients With Advanced Melanoma In the article accompanying this editorial, Jensen et al 20 provide an update on the READ ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Combination Immunotherapy for Advanced Melanoma—How to Choose? The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated ...
As pediatric palliative oncology physician-scientists studying communication and decision making in advanced cancer, quality of end-of-life care, and parental bereavement, we have encountered ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback